Indicator | Children (N = 80) | Adults (N = 57) | P* | |||
---|---|---|---|---|---|---|
 | n | % (95% CI) | TDHS2 | n | % (95% CI) |  |
Episodes treated | 80 | 100 (95.5–100) |  | 57 | 100 (93.7–100) |  |
Medications and dosaging: 1 | ||||||
Modern medicine | 80 | 100 (95.5–100) |  | 56 | 98.3 (90.6–100) | 0.416∞ |
Antimalarial drug (AM) | 71 | 88.8 (79.7–94.7) | 58.2 (88.6) | 47 | 82.5 (70.1–91.3) | 0.293§ |
- SP | 38 | 47.5 (36.2–59.0) | 23.7 (33.8) | 25 | 43.9 (30.7–57.6) | 0.673§ |
- SP correctly dosed | 13 | 16.25 (8.9–26.2) |  | 18 | 31.6 (19.9–45.2) | 0.035 § |
- amodiaquine | 10 | 12.5 (6.2–21.8) | 22.1 (29.3) | 5 | 8.8 (2.9–19.3) | 0.491§ |
- amodiaquine correctly dosed | 5 | 6.3 (2.1–14.0) |  | 3 | 5.3 (1.1–14.6) | 1.000∞ |
- quinine | 43 | 53.8 (42.2–65.0) | 11.9 (23.5) | 23 | 40.4 (27.6–54.2) | 0.122§ |
- other AM | 2 | 2.5 (0.3–8.7) |  | 1 | 1.8 (0.0–9.4) | 1.000∞ |
Antipyretic only | 9 | 11.3 (5.3–20.3) |  | 9 | 15.8 (7.5–27.9) | 0.438§ |
Antibiotic | 8 | 10.0 (4.4–18.8) |  | 2 | 3.5 (0.4–12.1) | 0.194∞ |
Treatment sources: 1 | ||||||
Health facility visit | 61 | 76.3 (65.4–85.1) |  | 32 | 56.1 (42.4–69.3) | 0.013 § |
AM from health facility | 43 | 53.8 (42.2–65.0) |  | 17 | 29.8 (18.4–43.4) | 0.005 § |
AM not from health facility | 28 | 35.0 (24.7–46.5) |  | 30 | 52.6 (39.0–66.0) | 0.040 § |
AM from drug store | 19 | 23.8 (15.0–34.6) |  | 26 | 45.6 (32.4–59.3) | 0.007 § |
AM from general shop | 8 | 10.0 (4.4–18.8) |  | 4 | 7.0 (2.0–17.0) | 0.761∞ |
AM from home stock (or relative/neighbour) | 10 | 12.5 (6.2–21.8) |  | 6 | 10.5 (4.0–21.5) | 0.723§ |
Exclusive home-management with AM3 | 14 | 17.5 (9.9–27.6) |  | 18 | 31.6 (19.9–45.2) | 0.055§ |